Head-To-Head Analysis: Precipio (NASDAQ:PRPO) versus Henry Schein (NASDAQ:HSIC)

Precipio (NASDAQ:PRPO) and Henry Schein (NASDAQ:HSIC) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability and earnings.

Institutional and Insider Ownership

10.4% of Precipio shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 16.6% of Precipio shares are owned by company insiders. Comparatively, 0.9% of Henry Schein shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

Precipio has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Precipio and Henry Schein, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precipio	1	0	0	0	1.00
Henry Schein	1	5	9	0	2.53

Henry Schein has a consensus target price of $92.93, suggesting a potential upside of 5.15%. Given Henry Schein’s stronger consensus rating and higher possible upside, analysts clearly believe Henry Schein is more favorable than Precipio.

Earnings and Valuation

This table compares Precipio and Henry Schein”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precipio	$24.05 million	1.99	-$360,000.00	($0.64)	-41.81
Henry Schein	$13.18 billion	0.75	$398.00 million	$3.43	25.77

Henry Schein has higher revenue and earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Precipio and Henry Schein’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Precipio	-4.47%	-8.49%	-5.75%
Henry Schein	2.96%	15.97%	5.56%

Summary

Henry Schein beats Precipio on 11 of the 14 factors compared between the two stocks.

About Precipio

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

About Henry Schein

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.